$Savara (SVRA.US)$Reuters· Savara to Present New Data From Pivotal Phase 3 Impala-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap) at the European Respiratory Society (Ers) Congress 2024 September 7th thru 11th
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
103073416 : nice
zezzzo : Don’t forget when I said will go to 7
Trytosaveabit OP zezzzo : Yup yup! GL and big profits to ya![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
zezzzo Trytosaveabit OP : Do you have any doubts about the stock?
Trytosaveabit OP zezzzo : Not the stock! But I do on how market makers may manipulate it if it gets a huge buy volume! JMO
zezzzo Trytosaveabit OP : Yes, it is possible. I trust your POV
Trytosaveabit OP zezzzo : Thank you for the kind words